Devapamil

This classification denotes a calcium channel blocker with the molecular formula C26H36N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M6142PTV7J, chemically known as 2-(3,4-dimethoxyphenyl)-2-isopropyl-5-((m-methoxyphenethyl)methylamino)valeronitrile but generally known as devapamil, which bears US NIH Compound Identifier 65832. European Medicines Agency schedules Devapamil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07015MIG. The term DEVAPAMIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). DEVAPAMIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule devapamil under HS 29269095 and SITC 51484. As of Q4 2014, DEVAPAMIL remains the US FDA Preferred Term for this commodity. Devapamil bears US NLM identifiers UMLS ID C0057583 and NCI Concept Code C77823. SMILES: O(c1cc(C(C(C)C)(CCCN(CCc2cc(OC)ccc2)C)C#N)ccc1OC)C.